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Abstract
Palliative care was established rapidly in some countries, while in other countries its establishment has taken a
different trajectory. This paper identifies core steps in developing a medical specialty and examines those taken by
Israel as compared with the US and England for palliative care. It considers the next steps Israel may take.
Palliative care aims to provide quality of life for those with serious illnesses by attending to the illness-prompted
physical, mental, social, and spiritual needs of patients and their families. It has ancient roots in medicine; its
modern iteration began against the backdrop of new cures and life-sustaining technology which challenged
conceptions of how to respect the sanctity of life.
The first modern hospice was created by Saunders; it provided proof that palliative care works, and this has
occurred in Israel as well (the first step). Another key step is usually skills development among clinicians; in Israel,
few education and training opportunities exist so far. Specialty recognition also has not yet occurred in Israel.
Service development remains limited and a major shortage of services exists, compared to the US. Research
capacity in Israel is also limited. Policy to develop and sustain palliative care in Israel is underway; in 2009, the
Ministry of Health established policy for implementing palliative care. However, it still lacks a financially viable
infrastructure.
We conclude that palliative care in Israel is emerging but has far to go. Adequate resource allocation, educational
guidelines, credentialed manpower and specialty leadership are the key factors that palliative care development in
Israel needs.
Introduction
The profession of medicine is in constant evolution.
With each new development, the health service delivery
infrastructure, healthcare policies, clinical providers, and
patient population all need to respond in order to
implement the development. During the decades of
rapidly occurring scientific breakthroughs, translation of
discovery into technology for use in existing specialty
practices was the main form of development and adap-
tation. Occasionally, however, a new specialty is created.
This is the case for palliative care.
Palliative Care as a Specialty
Ironically, palliation of suffering is perhaps the most
ancient and essential feature of medicine. During the
scientific era of the twentieth century, those goals were
underemphasized. Following the recognition by Cicely
Saunders [1] and soon after by Balfour Mount, that
patients’ humanity was getting lost in the quest for a cure
and the incurable were dying without comfort or closure,
the practice of modern hospice and palliative care was
born. Initially developed for the misunderstood and often
abandoned population of the dying, hospice started in
England as a type of care that occurred outside tradi-
tional healthcare settings, in care homes where people
could go to die in comfort, while in the US, hospice pri-
marily focused on providing a similar type of care in the
patient’s home. With Balfour Mount’s efforts in Canada,
palliative care was conceived as the same type of care but
it was seen as necessarily integrated with mainstream
medical services. Some three decades later, the term
“palliative care” refers largely to palliation for anyone
who needs it, no matter their prognosis; and the term
“hospice” tends to refer to end-of-life care. Suffering
was defined by Cicely Saunders as occurring in four over-
lapping domains of human experience: physical,
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psychological, social, and spiritual [2]. Palliative care,
whether in hospice or mainstream care settings, was
defined in various ways, but the definitions quite consis-
tently addressed management of suffering in all these
domains.
As pain and other symptom management became
scientifically complex and required skills as demanding
as in any recognized specialty, in country after country,
palliative care began to be recognized as a specialty
alongside cardiology, infectious disease and other main-
stream specialties. Today, palliative care’s integration and
development are not complete, but its relatively rapid
establishment has nonetheless been impressive. Different
countries have taken different trajectories. Today, in the
US, palliative care’s integration and development are not
complete, but its relatively rapid establishment has none-
theless been impressive. This paper examines the trajec-
tory taken by Israel, to date, as compared with that in the
US, and considers the next steps Israel may take.
Steps in Capacity Development for Palliative Care
Capacity development for a new specialty is not a stereo-
typical process. Nonetheless, some core steps are likely to
be identified and addressed by each country as it man-
ages its development. Scholars have described such devel-
opments in conceptual and social science terms [3]; here
we simply identify some of the steps that we feel are criti-
cal within the context of a comparative description of
progress in palliative care in Israel and the US.
A new specialty’s history is likely to start with the
recognition of a need. Then a pioneer program demon-
strates that the need can be met. With this “proof of con-
cept,” or demonstration of efficacy and feasibility in one
setting, the core content of what that specialty offers can
be defined and brought as a new skill-set to practitioners.
Many barriers must be overcome just to reach this stage,
but the next challenges are also great. In order for the
skill-set to be taken up and used, not only the culture of
medicine but also the culture of the population must be
receptive to and desirous of the services. These develop-
ments need to be matched with new policies that support
the services. With increased use of services, quality con-
trol becomes necessary; a specialty association with stan-
dards, protocols and norms, and formal specialty
standing within the medical profession, with specialist
provider accreditation, is the traditional setting for qual-
ity control. This provides the necessary support for crea-
tion of specialty training programs, development of an
adequate number of providers in the discipline, and dis-
semination of core skills to all providers, so that the ser-
vices can be made available to all who need them.
To further the field, the establishment of research
resources and research skills suitable to the subject mat-
ter among professionals then becomes possible and
necessary. Policy that supports the services and research
may then be supported and refined by evidence. Later
stages in the development of a mature field include inte-
gration of the specialty services with other services,
ensuring access to and use by as full a population of
those who need the services as possible, and finally, sus-
tained continuous quality improvement. These steps [4]
are listed below and are described below with a focus
on Israel’s development of palliative care against the
backdrop of its evolution in other countries, especially
the US, ending with recommendations for Israel’s next
steps for the establishment of palliative care as an inte-
grated service within the institution of medicine. These
steps and their order are not intended as absolute
requirements and it is reasonable to assume that the
optimal path differs with country.
Archetypal steps in the development of a new speci-
alty in medicine
1. A need is perceived
2. An entity establishes that the need can be effectively
met (proof of concept)
3. The core subject matter of the area is defined
4. Skills to match the subject matter are developed for
the workforce
5. The culture of medicine and the population served
want the services
6. Specialty associations form and formal bodies
recognize the area as a specialty
7. Capacity is developed through disseminated training
and local service units
8. Research capacity to continue the specialty’s
advancement is developed
9. Policy to support the service delivery and research
is created
10. Maturation of the services develops, scaling and
establishing quality control
1. Perceived Need
Awareness of the needs of the dying took shape in the
setting of emerging life-sustaining technology in the
1970s and with the discovery that it is possible to exist in
a persistent vegetative state. The first country that began
to talk about taking back control of the dying process out
of the hands of medicine was the UK, where Dame Cicely
Saunders founded the St Christopher Hospice in London
in 1967; that was the first modern hospice [5]. Many
Western countries, including the US, embraced the idea
of hospice care. In 1969, Florence Wald, who is accre-
dited with bringing the hospice movement to the United
States, invited Saunders to the US to learn from her
experience [6]. Grassroots efforts to develop hospice care
further during the 1970s led to a Health Care Financing
Administration demonstration project at the end of the
decade, and the passage of the Medicare Hospice Benefit
by the US Congress in 1982 [7].
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In the US, the same concerns resulted in advocacy for
living wills to legally direct physicians to withhold or
withdraw unwanted life-sustaining technology. In 1990,
the Patient Self Determination Act (OBRA-90, Pub. L.
101-508, 104 Stat. 1388, enacted on November 5, 1990)
required that all patients be asked if they have such
determinations. A parallel movement went further,
demanding the right to assisted suicide or euthanasia.
Eventually, the United States Supreme Court recognized
the right of an individual to refuse unwanted medical
treatment, leaving the creation of laws concerning
assisted suicide and euthanasia to the individual states.
Patient and family experience in hospice care was so dra-
matically better than their experience of traditional hos-
pital care that, by the time New York passed the
Palliative Care Information Act in 2010 (Chapter 331,
section 2997-c of the New York Laws of 2010) [8] requir-
ing that all terminal patients be informed of hospice and
palliative care options, public perception had already
established hospice care as the culturally expected stan-
dard of care for the terminally ill.
In Israel, awareness of the individual’s rights regarding
end-of-life decisions exists, but there are cultural con-
cerns that impede its development into reality and policy.
For many Jews in Israel the concept of “sanctity of life”
(kedushat hakhayim) is a central value [9-11]; this contri-
butes to a tendency for patients to request and for physi-
cians to provide “aggressive” modes of care even as
patients approach the end of life. The community is plur-
alistic and substantial segments of the public and health
professionals reject this outlook and would prefer end-of-
life practices found in other countries. Consequently,
health providers in Israel face the challenge of respecting
personal autonomy and supplying quality end-of-life
care, while also taking traditional values into account.
This situation is further complicated by a lack of wide-
spread familiarity with palliative care precepts among
many healthcare professionals. Indeed, among the public,
many fear that, in the terminal stages of their lives, they
will receive more medical care and less pain relief than
they want [12].
Responding to prolonged public pressure, the govern-
ment has initiated efforts to tackle end-of-life issues. In
2000, Israel’s Minister of Health established a public
committee on the sensitive issue of end-of-life care. The
committee was chaired by Rabbi Avraham Steinberg -
who is also an ethicist and professor of medicine - and
included representatives of different Jewish denomina-
tions, the larger minority groups within Israel, physicians,
philosophers and ethicists. In 2005, the Dying Patient Act
was enacted in Israel [13].
In 2004, the director-general of the Ministry of Health
appointed a professional committee to formulate recom-
mendations for setting guidelines for palliative care in
Israel. The committee was headed by Prof. Pesach
Schwartzman and included experts from the national
councils for community health, oncology, palliative care,
geriatrics and children’s health. In 2009, the director-
general of the Ministry of Health issued a directive pol-
icy statement describing standards for the development
and provision of palliative care services for hospitals and
the health plans.
2. Proof of Concept
A long history of pre-modern hospice care in Europe
and the Holy Land dates back to the Middle Ages. Hos-
pices were religiously motivated charitable places that
gave care to the sick and dying - mostly along the Cru-
sader and pilgrims paths [14]. Modern hospice is very
different; indeed, its only common theme with past hos-
pices is care for the dying. Palliative care is defined by
the World Health Organization as follows:
Palliative care is an approach that improves the quality
of life of patients and their families facing the problem
associated with life-threatening illness, through the pre-
vention and relief of suffering by means of early identifi-
cation and impeccable assessment and treatment of pain
and other problems, physical, psychosocial and spiritual.
Palliative care provides relief from pain and other distres-
sing symptoms; affirms life and regards dying as a normal
process; intends neither to hasten or postpone death;
integrates the psychological and spiritual aspects of
patient care; offers a support system to help patients live
as actively as possible until death; offers a support system
to help the family cope during the patients illness and in
their own bereavement; uses a team approach to address
the needs of patients and their families, including
bereavement counseling, if indicated; will enhance quality
of life, and may also positively influence the course of ill-
ness; is applicable early in the course of illness, in con-
junction with other therapies that are intended to
prolong life, such as chemotherapy or radiation therapy;
and includes those investigations needed to better under-
stand and manage distressing clinical complications.
http://www.who.int/cancer/palliative/definition/en/.
The above-mentioned first hospice, started by Saun-
ders, provided proof that the hospice and palliative care
concept could be used. The overwhelming satisfaction
of patients and families served by her freestanding hos-
pice proved that the concept was not only feasible but
also desirable. Like-minded institutions made the case in
other countries. One was opened in Connecticut in the
US [6] and another, opened soon after, became the first
to take patients in Chicago, Illinois. In 1975, one was
established at the St Luke’s Hospital Center in New
York: It incorporated into an existing medical center an
array of services ranging from inpatient care, home care,
clinic care, to bereavement counseling for families. All
were successful and established the integrated care that
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Saunders envisioned, as did the Medicare hospice bene-
fit, which required that care be provided in both the
home and inpatient settings, and included psychosocial
care, spiritual care, and bereavement care alongside
medicine and nursing as required services.
Interest in establishing the efficacy and effectiveness of
the model in Israel began about three decades ago. In
1981, the head of the Geriatric department at Sheba
Medical Center in Tel Hashomer, Dr. Israel Abraham
Adunski, traveled to England after hearing of the work
of Cicely Saunders and was duly impressed. Following
the visit, he established a committee to discuss the pos-
sibility of developing adequate services for the terminally
ill and their families. With the help of the Israel Cancer
Association, this led to the establishment of the first
inpatient hospice in Israel, in 1983, and in 1986, the sec-
ond inpatient hospice opened in Jerusalem, at Hadassah,
Mount Scopus [15].
By the early 1980s, recognition and awareness of pallia-
tive care needs led to the first community homecare ser-
vice with a component of palliative care, which was run
by nurses funded and trained by the Israel Cancer Asso-
ciation. In 1978, these nurses developed postgraduate
specialist oncology training that included a component of
palliative care and symptom management. This created a
viable option for terminal patients wishing to be cared
for at home. First, the nurses worked as part of the family
physician system, and later as part of homecare and
home-hospice community health teams. During the late
1980s and the 1990s, seven home-hospice units were
opened all over the country, supplying palliative care for
cancer patients. However, they dealt almost exclusively
with cancer patients and did not provide for patients
with chronic illnesses [16,17].
In 1983, the first home hospice for adult cancer
patients run by volunteers was funded in Kiryat Tivon
[18] and in 1994, a nonprofit home hospice was founded
by Prof. Nancy Caroline, in northern Israel, in order to
provide palliative care support for the families of patients
from all sectors of society - Jews, Moslems, Christians,
Druze and other groups. In an effort to provide palliative
care services to another remote area, a Bedouin mobile
palliative care unit was established in the Negev desert,
in 2004, in order to reach isolated places [19].
In 1994, the Shaare Zedek Medical Center established
the first cancer center fully integrating oncology and
palliative care services, under the leadership of Prof.
Raphael Catane and Dr. Nathan Cherny [20]. This initia-
tive was followed by the development of similar services
in the cancer centers at the Rambam Medical Center in
2003, and at the Davidson Cancer Center in 2008. More
limited programs exist in other medical centers. For
example, in 2002 an ambulatory palliative service was
implemented in Soroka University Medical Center
including both an adult oncology department and a
pediatric hematoncology department that provide hospi-
tal-based adult and pediatric palliative care consultation
and support at the regional hospital in southern Israel
[21].
The Israeli Association of Palliative Care (Tmicha/
IAPC) was established in 1993, as a voluntary organiza-
tion for all health professionals, trained volunteers, and
interested lay people who identify with its philosophy
and are actively involved in palliative care in Israel. It is
active in encouraging professional and public education
and in promoting the development of services. The
association places emphasis on the importance of multi-
disciplinary collaboration between health professionals,
produces a quarterly newsletter and organizes an annual
professional conference. The Israel Palliative Medical
Society (IPMS) was established in 1996, as a branch of
the Israel Medical Association. The aim of the IPMS is
to represent physicians practicing palliative medicine
and to promote palliative medical services, education
and research. Both Tmicha and the IPMS are members
of the European Association for Palliative Care (EAPC)
[22,23].
In the mid-2000s, the UJA-Federation of New York
introduced the field of spiritual care and chaplaincy in
Israel, in order to provide a comprehensive and holistic
response, similar to the work being done in New York.
In early 2006, it launched a major new funding initiative
for the development and provision of spiritual care ser-
vices and training programs in Israel [24,25]. The first
chaplaincy program was established at the Shaare Zedek
Medical Center in 2002, and shortly thereafter, a cha-
plaincy-training program was launched with the support
of the UJA-Federation of New York. Subsequently, a
network of chaplaincy and spiritual care providers was
established.
3. Core Content Defined
Guidelines for defining the core content of the field of
palliative and hospice care were initially guided by the
Oxford Textbook of Palliative Care from England. Fund-
ing by the Robert Wood Johnson Foundation in the
1990s of a series of professional education programs -
for nurses, physicians (non-palliative care specialist) and
specialty fellows - provided the vehicle against which to
define the core content of palliative care. The curricu-
lum contents were decided by expert consensus groups
from across the US [4]. This was followed by the
National Guidelines project and several US textbooks
[26,27].
In 2005, the Israeli Ministry of Health commissioned
an expert report to define core content of palliative care
services. This report was supplemented by additional
inputs from the Society of Palliative Medicine Physi-
cians. Based on these reports and submissions, in July
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2009 the director-general of the Ministry of Health
issued a policy statement describing minimal standards
for the development of palliative care services for hospi-
tals and for the provision of home palliative care by the
health plans [28].
4. Skill Development among Clinical Providers
Skill development among clinicians, nurses and other
healthcare professionals is essential in order to dissemi-
nate palliative services. Without proper training, there is
no prospect of furthering the provision and access of
services. In the US, core competencies were provided
over a 10-year period by the above-mentioned education
dissemination projects, and then by post-graduate speci-
alty training for physicians and nurses [4]. Currently,
there are about 60 palliative care fellowships in the US.
Palliative care specialists must have satisfactorily com-
pleted a year of full-time clinical care in a fellowship
program and pass the American Board of Medical Spe-
cialties’ hospice and palliative medicine written exam.
In Israel, there are only a few frameworks that offer
education and in-service training on the subject. All
programs that have existed have been temporary and
funded by donations. The curricula of training programs
for health professionals (both undergraduate and post-
graduate) provide very little formal training in palliative
care. Issues relating to suffering and terminal illness
have been included in the curricula of medical and nur-
sing schools only as part of general topics such as ethi-
cal issues or pain management [29,30]. Courses
providing more comprehensive training existed but were
discretionary, and were offered only in hospitals or in
training programs in which there were particularly moti-
vated educators and/or clinicians.
In an attempt to meet the needs of health professionals
for palliative knowledge and skills, a program was
launched in 2005 - a collaboration between the UJA Fed-
eration of New York, ESHEL (the Association for Plan-
ning and Developing Services for the Aged in Israel),
Ben-Gurion University of the Negev, and the “Support”
organization (a multi-disciplinary organization for pallia-
tive care in Israel). The aim was to develop and imple-
ment a national, interdisciplinary training program in
palliative care, for physicians, nurses, and social workers.
This would increase the awareness and knowledge of
healthcare professionals in the principles of palliative
care and expand the scope and quality of palliative care
provided to patients and their families throughout Israel.
The courses comprise six sessions, follow a uniform 43-
hour curriculum, and are carried out all over the county,
in hospitals, health plans and a few nursing homes
[31,32]. To date, more than 1,200 participants have taken
part - about two-thirds of them nurses, a sixth social
workers, and a sixth physicians, as well as a small number
of professionals from other fields. Since the UJA funding
expired, the ongoing costs have been covered by the
health plans, hospitals and nursing homes.
The external educational departments in the universi-
ties invite professionals to participate in enrichment and
continuing medical education courses in which they can
earn points toward receiving continuing education
grants. These courses are similar to the American CME
only in that they entitle participants to receive a grant
in addition to their salary. (In Israel, professionals,
including doctors, are not yet required to prove that
they have participated in the continuing educational
courses or to take repeat licensing tests.) The courses
are not funded by the universities and therefore the par-
ticipants are required to pay for them.
These were the main courses:
a. Tel Aviv Medical School: Palliative Medicine - This
one-year program, established in 1998, includes some
300 hours of teaching and seminars. Although ostensibly
for physicians, this course has also included nurses and
pharmacists (not every year; this year it is not taking
place).
b. Social Sciences Faculty in Tel Aviv University -
Enrichment courses for gerontologists: four meetings on
the topic of the right to quality.
c. The Ben-Gurion University Medical School with the
Israel Association for Prevention of Pain - Pain manage-
ment course [33].
Unfortunately, most of these programs were term lim-
ited. Other education and training programs for profes-
sionals caring for patients with life-threatening diseases
or the elderly exist, but they are not systematic or inte-
grated into the education systems.
5. Cultural Alignment
The US culture of youth and a sense of invulnerability
fostered a culture of death denial such that, until the
1980s, care near the end of life was neglected. With the
advent of the persistent vegetative state, the US culture
started to examine old and new realities of dying. The
movement to control dying by planning in advance with
documentation of wishes began in the 1970s, and devel-
oped in parallel with the euthanasia movement [34].
Although small pockets in the US, starting with Oregon,
passed legislation to legalize physician-assisted suicide,
the main outcome of the effort nationally was to recog-
nized the right of an individual to refuse unwanted medi-
cal treatment (Washington v. Glucksberg, 117 S.Ct. 2258
1997, Vacco v. Quill, 117 S.Ct. 2293 1997). With the
aging of society and the burdens of the “sandwich gen-
eration” (struggling financially to care for their aging par-
ents while providing for their high-school and college-
age children) increasing in the 2000s, people began to
seek realistic solutions to aging and dying. Today, hospice
and palliative care are household words and part of the
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normative expectations of many or most citizens who are
seeking quality care for the seriously ill and dying.
The relationship between religion and state is a crucial
issue in culture, identity and political life in Israeli
society, including palliative care [35]. Judaism is a religion
of laws pertaining to everyday life [36]. The sanctity of
human life (kedushat hakhayim) is a central value in
Israeli culture and human life is deemed of infinite value.
These beliefs were echoed in the results of a study that
compared physicians’ attitudes in Israel and the United
States towards end-of-life decisions. There were more
respondents in Israel than in the US (72% vs. 57%) who
said their professional duty was foremost to preserve the
patient’s life [37]. Nonetheless, Judaism also recognizes
that all life is finite and therefore is compatible with the
philosophy of palliative and hospice care. Relief of suffer-
ing is deemed important. The process of dying must be
respected when it is clearly occurring, imminent, and
irreversible [38]. Although most Jewish people do not
strictly adhere to Jewish law, these tenets do impact on
beliefs and culture. In Israel today, there is a desire to
merge cultural identity and heritage with democratic and
liberal values. These issues were addressed in the com-
mittee chaired by Professor Steinberg, which found a
solution that resolved the tension between the right of
individual autonomy and Israeli cultural heritage [13].
People with diverse beliefs and values were able to bridge
the gap between individual autonomy, death with dignity,
and avoidance of prolonged suffering.
Almost no empirical data are available in Israel con-
cerning the knowledge, attitudes and perceptions of the
public regarding palliative care, and there is limited
information on the knowledge and perceptions of gen-
eral practitioners and specialists. This was confirmed in
the results of a qualitative study that examined the
Israeli family physicians’ attitudes towards the Dying
Patient Act, which found that very few physicians dis-
cussed end-of-life care or the option of advance care
planning with their patients. Although the physicians
are aware of the option of preparing an advanced direc-
tive or of appointing a healthcare proxy for end-of-life
issues, they are concerned about cultural barriers to
implementing the act [39].
There are no robust statistics on how many people are
referred to palliative care; however, considering the lim-
ited and patchy availability of services and the miscon-
ceptions that abound, overall referral is low. For many,
palliative and hospice care are perceived to be the “end
of the road” or “the last stop.” Some patients and their
families are skeptical about palliative care even when it
is offered to them, and some even refuse the services.
However, in those institutions or regions with well-
developed local programs, there are reports of very high
resource utilization.
In recent years, several television and newspaper stor-
ies have followed the “struggle” of cancer patients,
mostly children. Although some of them died, in most
cases, aspects relating to their end-of-life care were not
described. With few notable “positive” exceptions, the
popular press rarely offers stories of people facing end-
of-life situations. One recent well-known example is
Mr. Dov Lautman, an industrialist and philanthropist,
who is frequently interviewed in the press or television
about how he is facing ongoing neurological functional
deterioration of his situation because of ALS and is, at
the same time, continuing his philanthropic activities.
6. Specialty Recognition
The American Board of Medical Specialties in the US
recognized hospice and palliative medicine as a disci-
pline in 2006. Education had been proceeding prior to
that so that a number of fellowship programs were
available for specialty training in the area already, and
board certification had been offered by the American
Board of Hospice and Palliative Medicine. After speci-
alty recognition, compliance with standard regulations
for supervised training was adopted.
Specialty recognition in Israel is determined by the
Scientific Committee of the Israel Medical Association.
Several attempts have thus far been made to apply for
specialty recognition by the Association of Palliative
Medicine Physicians within the Israel Medical Associa-
tion and through the Israel Association of Palliative Care.
A substantial limiting factor that has precluded progress
has been the strict regulatory requirement that there be
at least two fully trained mentors in each training institu-
tion, and furthermore that there be more than one train-
ing institution in the country. A further application is
pending. The Scientific Council has presented the possi-
bility of developing a fellowship program as a stepping
stone to the later development of an independent speci-
alty, once the obstacles of manpower thresholds are
overcome.
In 2009, an injunction was signed recognizing pallia-
tive care as a specialty for nurses [40]. This action
brought an end to the long struggle led by Dr Shoshana
Riba, Head Nurse and Chief Nursing Officer to create a
new professional status for nurses in Israel. Veteran pal-
liative care nurses who have undergone advanced train-
ing in various settings have been granted recognition as
clinical nurse specialists Two Israeli universities are cur-
rently developing formal academic programs and gradu-
ates will be required to undergo licensing examinations
[41].
7. Service Provision
Hospices exist in the US that are freestanding, non-
profit, freestanding for profit, chain for profit, and asso-
ciated with larger health organizations. Little is known
about differences, if any, in quality between the types. A
Bentur et al. Israel Journal of Health Policy Research 2012, 1:9
http://www.ijhpr.org/content/1/1/9
Page 6 of 13
study that used a nationally representative data set of
hospices surveyed in the National Home and Hospice
Care Survey, 1992-2000, found Medicare hospice certifi-
cation was associated with a significantly broader range
of services provided to patients and it was significantly
more pronounced among for-profit hospices than
among nonprofit [42].
Palliative care services that combine this type of care
with traditional care in many disciplines are also
increasingly available: A hospital-based consulting ser-
vice usually provides care at the request of the attending
physician from wherever the patient is receiving his or
her predominant care - cardiology, oncology, surgery,
etc. Some of these palliative care services have dedicated
beds and their own service for patients for whom pallia-
tive care becomes the primary type of care. These dedi-
cated beds are served exclusively by palliative care
physicians, nurses and other disciplinary members of
the palliative care team, and non-palliative care clini-
cians take on a consulting role. Other, usually smaller,
palliative care services provide their care wherever the
patient is, without the option of moving to a dedicated
palliative care service bed. Much of the successful disse-
mination and development of service capacity in the US
was due to the funding of the Center to Advance Pallia-
tive Care, and the finding by researchers of empirical
data consistent with a robust business case allowed its
integration to move forward rapidly against the back-
drop of spiraling healthcare costs [43,44]. The imple-
mentation of the Affordable Care Act of April 2010 is
still emerging http://www.healthreform.gov/index1.html,
but increased funding for home-based care may improve
use of palliative care as well.
Israel’s Ministry of Health has declared that palliative
and hospice services are covered under the basket of
services that every health plan should supply to their
enrollees according to the National Health Insurance
Law [28]. Indeed, the law stipulates that the health plans
have to provide their members with all necessary ser-
vices within the framework of a mandated benefits pack-
age. However, certain issues and services are not
sufficiently defined or clarified by the law: The law does
not include detailed eligibility criteria for palliative care,
nor does it provide formulation of the process of deter-
mining eligibility, and there are no directives on how to
decide which services will be permitted to refer a patient
for palliative or hospice care. The Law does not deter-
mine the framework for the provision of this care, the
types of care that people are eligible to receive, the fre-
quency and scope of care, or the professions and educa-
tion of those providing palliative care.
Hospital- and community-based palliative and hospice
services do exist in Israel, but to a very limited extent.
As of 2010, few hospitals provide consultative or
inpatient palliative care services. Three hospitals - the
Shaare Zedek Medical Center in Jerusalem, Rambam
Medical Center in Haifa, and the Belinson Medical Cen-
ter in Petach Tikva - each have well developed palliative
care services for cancer patients that have met all the
criteria for the ESMO designation in integrated oncol-
ogy and palliative care. These services include consulta-
tion services, ambulatory palliative care, inpatient
palliative care, and close correlation with community
resources for home care. Others hospitals have more
limited services, with the availability of either a part-
time palliative care consultant physician or nurse. Most
of the 15 cancer centers in Israel do not have any desig-
nated physicians responsible for palliative care services.
There are three inpatient hospices in Israel - in Jerusa-
lem, Tel Aviv, and Haifa - which have been allotted a
total of about 80 beds, and serve some 1,000 patients
per year. Additionally, 3-4 hospitals belonging to the
Christian Mission take in end-of-life patients who can-
not be at home but have not yet reached the hospice
stage, or for whom there is no hospice in their vicinity.
They offer dedicated care, but the staff’s palliative train-
ing is very limited.
There are about 8 home-hospice units all over the
country. They rely on multiple sources of financing,
such as Clalit’s Health Plan (the biggest of Israel’s four
health plans) budgets, the sale of services to other health
plans, and mainly philanthropic contributions. Conse-
quently, there is no steady supply of funds to these
units, making their existence precarious, and impeding
their ability to expand their activities.
Only a few of the physicians working in the home-hos-
pice units have formal training in palliative care, but
almost all of the nurses have studied more than a basic
level of oncology and/or palliative care in Israel or abroad.
The home-hospice units differ significantly in their pat-
terns of care. Each unit has established procedures that
govern the number of regular physician and nurse visits.
The staff is usually available 24 hours a day, in person and
by telephone. About two-thirds of home-hospice patients
are treated simultaneously by other services - primarily by
community clinics and oncology services in hospitals.
Overall, opioid availability and accessibility for cancer
patients is good. A wide range of opioids is available for
the management of moderate and strong cancer pain.
Morphine, oxycodone and transdermal fentanyl are
widely used. There is less use of parenteral hydromor-
phone and oral methadone, though both are available.
Transmucosal fentanyl is available to patients who have
not had adequate relief with oral immediate release for-
mulations or in situations where oral medication is con-
traindicated. For cancer patients, medications covered in
the non-discretionary basket of services, which include
all opioids, are dispensed at no cost.
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Prescriptions do not require any special forms and
need not be in duplicate or triplicate. They must include
personal details, including identification number and
address, and the prescription must be written both in
numbers and in longhand. If a patient presents with a
prescription that has a technical error, pharmacists have
little or no discretion to honor or correct the prescrip-
tion and the patient must return with a fully valid pre-
scription. In general, prescriptions are valid for a 10-day
supply of medication. However, if there is an annotation
that the patient suffers chronic cancer pain, prescription
for a 30-day supply is permitted. Most opioids are
widely available in community pharmacies and patients
need not present themselves to special pharmacies. The
regulations regarding opioid prescription and dispensing
make no provision for emergency physician prescrip-
tions by telephone or fax, or emergency prescriptions by
nurses or by pharmacists.
Israel saw a modest increase in opioid consumption in
the years 2000-2008 and a rapid increase per capita in
opioid consumption during the former decade. Data for
the 2000-2008 period (for all treatment settings, private
and public) show that consumption of the five strong
opioids (requiring a special prescription form) increased
by 47%, from 2.46 DDD/1,000 inhabitants per day in
2000 to 3.61 DDD/1,000 inhabitants per day in 2008.
This has been associated with substantial changes in the
pattern of differential opioid prescribing, characterized
by increased prescription of oxycodone, fentanyl, bupre-
norphine, and dextropropoxyphene, and decreased pre-
scription of morphine, pethidine, and codeine [20,45]. A
seven-year follow-up study indicated an increase in
opioid prescriptions for cancer and non-cancer pain
with an annual increase in OME per capita. During the
study period, there were no relevant changes in regula-
tions and policy [46].
In addition to the previously described palliative care
services they have already committed to, Israel’s four
health plans operate home medical care units in all of
their districts, which provide medical, nursing, and reha-
bilitative home care. These units treat housebound indi-
viduals, mostly elderly, who suffer from a variety of
chronic and functional disabilities. The units supply pal-
liative care for about 5,000 patients with metastasized
cancer and neurologic and degenerative diseases per
year. However, they almost never provide palliative care
for dying dementia patients. Generally, staff of these ser-
vices are available during working hours only. Although
some are on call by telephone until evening, with some
exceptions they are not generally available to provide
services in the evening and at night.
The palliative care credentials of members of these
teams are very varied, and some have no formal training
in palliative care. However, most of the homecare units
employ oncology nurses on staff, who are available by
telephone 24 hours a day. These oncology/palliative care
nurses are credentialed and have received oncological
and/or palliative training in Israel or abroad. For the
most part, these nurses guide other community health-
care providers in coping with complex situations and
sometimes care directly for dying patients. They play a
central role in coordinating hospital and community ser-
vices, developing and implementing oncology and pallia-
tive projects in their district, training medical personnel,
and overseeing this type of care in their district [47].
8. Research Capacity Development
In the US, funding for research in palliative care began
with the National Cancer Institute, an institute within
the National Institutes for Health - the main govern-
ment funding agency for medical research. Its primary
purpose is funding for cancer research, and palliative
care has been included, in recognition that palliative
care is a part of comprehensive cancer care. The Ameri-
can Cancer Society research arm followed suit and has
provided research funding for palliative care as well.
Most recently, the National Palliative Care Research
Center was created as a part of the Center to Advance
Palliative Care, with the mission to provide grant sup-
port to researchers and career development awards to
incoming researchers in palliative care. Institutes for
other areas of medical care, such as the National Heart
Lung and Blood Institute, are increasingly aware of the
need to support research in palliative care for their
population of patients.
There are several research groups in Israel that are
involved in conducting clinical and health services
research in the area of palliative care, in order to
improve services provided to patients and their families.
These include researchers at Ben-Gurion University of
the Negev, the Shaare Zedek Medical Center in Jerusa-
lem, and the Myers-JDC-Brookdale Institute in Jerusa-
lem. In addition to clinical topics, the issues examined
include the improvement of service organization and
options for their expansion, training needs, quality of
care, and the cost of providing palliative services to end-
of-life patients compared to the cost of non-palliative
care.
Most of the research grants in Israel, whether from
academic institutions, the Ministry of Health, or the
National Institute for Health Policy and Health Services
Research, are not earmarked for a specific area. Pallia-
tive researchers must compete with researchers in other
areas that are sometimes considered more important or
more urgent. Indeed, studies on the quality of care for
end-of life-patients have often been shelved after receiv-
ing low marks with regard to their importance.
There are no organizations that focus on funding
research on palliative care in Israel and, similarly, there
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has been no effort to develop researchers with suitable
career tracks and training to do the research.
The palliative care organization in Israel have not
initiated any multi centers studies and they have no fra-
mework for collaborative research. Individual research-
ers, however, have been productive and have published
substantially and Israeli specialists and researchers are
involved in the Expert Working Group of the Steering
Committee of the Research Network of the European
Association of Palliative Care, that revised and updated
the guidelines on the use of morphine in the manage-
ment of cancer pain [48,49], the use of sedation in pal-
liative care [50], and other topics.
So far, palliative research has focused predominantly
on cancer patients with much less research addressing
palliative care for other chronic conditions.
9. Policy
To become available, hospice care needed a mechanism
of reimbursement for its services, on a par with other
medical services. In 1979, the Health Care Financing
Administration began demonstration projects with 26
hospices. By 1986, the Medicare (the US medical benefit
for the elderly) Hospice Benefit, which provides services
to all with a prognosis of 6 months or less to live, was
made permanent. Some states also provide hospice to
Medicaid (the US medical benefit for the poor) eligible
patients [51].
In addition to reimbursement policies, information has
been essential in the uptake of service use. The (above-
described) 1990 Patient Self-Determination Act (that
requires healthcare organizations to ask patients about
advance care planning and to conduct community out-
reach regarding advance care planning) and several state
laws that provide for the use of transportable Physician
Orders for Life Sustaining Treatment (POLST) [52] or
that require provision of information about hospice and
palliative care to terminal patients (see above-noted
New York Palliative Care Information Act), have aided
awareness and use of hospice and palliative care services
in the US.
In Israel, the Dying Patient Act has been enacted. The
law reflected an actual, tangible need among healthcare
professionals and the Israeli public. The most distin-
guishing feature of the Dying Patient Act was the
attempt to respect cultural reluctance to withdraw treat-
ment while offering a practical solution that respects the
wishes of patients and families, and allows patients to
end their lives with dignity. The law supported the right
of terminally ill patients with a life expectancy of less
than 6 months to formulate advance directives that may
include the forgoing of treatments and the withdrawal
of ventilator supports. The Orthodox population’s objec-
tions to the withdrawal of ventilators were mitigated by
the proposal of changing ventilator support to an
intermittent treatment by virtue of timers which would
allow for the non-initiation of a further cycle of therapy.
The decision to end life support could be made by not
resetting the timer rather than active termination, satis-
fying the Jewish law that prohibits the active deed of
ending one’s life. The infrastructure for this solution is
only now, 5 years after the legislation, in a testing phase
and it has not yet been implemented. Presently, there
are no statistics concerning the number of individuals
filling out Advance Directives documents. According to
an interview with the Chief Officer of Medical Ethics at
the Ministry of Health, in charge of implementing the
Dying Patient Act, they have received approximately
2,000 advance directive documents to be approved and
entered into a database.
The director-general adopted the policy paper that
was submitted by the committee in 2005. The policy
paper adopted the definition of the WHO, according to
which palliative care is a therapeutic approach aimed at
improving the quality of life of patients coping with
incurable diseases and their families, by preventing and
relieving suffering via identification and careful evalua-
tion of symptoms, by management of pain, and by deal-
ing with other issues, such as physical, mental and
spiritual problems. In mid-2009, after a long period of
debates and discussions, the director-general of the
Ministry of Health published a policy statement for the
implementation of palliative care in the healthcare sys-
tem. The circular defines the target populations for pal-
liative care services as patients with considerable
physical and emotional distress at any disease stage,
including terminally ill cancer patients, patients with
end-stage heart failure, patients with end-stage lung dis-
ease, patients with end-stage liver failure, patients with
end-stage renal failure, patients with severe stroke,
patients with advanced neurodegenerative disease, and
unconscious patients. It defines minimal standards for
palliative care services, which must include a physician,
a nurse, a psychologist and a social worker. The docu-
ment also details credentialing, and hours of availability.
According to the directive, the health plans, the general
hospitals, and long-term care institutions, have to make
all arrangements required for provision of these services
within four years of the issue of the directive, and have
to report to the Head of Medical Administration on
their progress towards service implementation within
one year of the publication of the directions. This initia-
tive was not accompanied by budgetary expansion speci-
fic to this purpose.
10. Maturation: Scaling Up and Quality Control
In the US, increasing citizen and professional awareness
and increasing service availability have driven up the uti-
lization of hospice and palliative care considerably over
the last decade. For 2009, NHPCO estimates that
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approximately 41.6% of all deaths in the United States
were under the care of a hospice program [53]. A great
majority of health delivery organizations now provide,
or are affiliated with organizations that provide, pallia-
tive and hospice care [54]. The Joint Commission (pre-
viously the Joint Commission on Accreditation of
Healthcare Organizations or JCAHO) has provided,
since 1984, voluntary accreditation to hospices and pal-
liative care services. As with other healthcare organiza-
tions and services, they periodically and randomly visit
any entity that seeks their accreditation. Evaluating the
state of services by examining facilities and records and
by interviewing providers, they discern whether their
criteria for quality are met and provide their seal of
accreditation, or not, accordingly. More generally, the
medical system in the US is increasingly aware that
research and adoption of accreditation standards are not
enough to improve practice standards. The combination
of research in palliative care with the emerging field of
dissemination and implementation research will be
necessary [55].
In Israel, hospital- and community-based palliative
and hospice services exist, but it is estimated they serve
less than 10-15% of those who could benefit from them.
However, as noted above, there are no robust statistics
on how many people are referred to palliative care, but
considering the lack of services and the misconceptions
that abound, referral is probably very low.
Although a large proportion of the residents of long-
term care institutions suffer from multiple symptoms at
the end of life, most of these institutions abide by con-
servative treatment methods, which consist primarily of
medication to alleviate pain and other physical symp-
toms. A few geriatric hospitals and institutions have
recently begun implementing the hospice approach, by
providing psychological and emotional support while
treating physical symptoms.
There is no sustained quality assessment and improve-
ment and/or any regulatory agency, voluntary or man-
dated, that has formulated a set of criteria to be met,
that assesses the quality of services, that gives accredita-
tion to the palliative service organization, or refuses the
accreditation depending on whether or not the service
organization meets its criteria.
In January 2011, the Ministry of Health started to
assess implementation of the ministerial directive by
health plans and hospitals. It will also verify whether
organizations have formed a multidisciplinary team to
supply palliative services, and if appropriate training was
provided.
Next Steps for Palliative Care in Israel
Tracking the development of palliative care according to
the archetypal steps we defined, reveals that the belief
that every individual has the right to palliative care at
the end of life is gaining ground in Israel. Israel has
clearly made significant progress, yet palliative services
have not been widely accepted as a fully integrated ser-
vice in the nation’s healthcare delivery system, and
therefore further steps are needed.
As professional skill development is essential in order
to develop, implement and disseminate palliative services,
there needs to be significant expansion in education and
training in this field. There is no standard curriculum for
current programs that offer palliative education at gradu-
ate level in medical and nursing schools. There is a need
to construct a palliative care curriculum - a modular and
dynamic model for teaching medical students, residents,
fellows, practicing doctors and other health professionals.
In addition, the development and implementation of an
obligatory palliative training program is necessary for stu-
dents in all health professions, and for other professionals
dealing with elderly and chronic patients.
In the post-graduate framework there are few programs
that offer education and in-service training on the sub-
ject. While the basic courses that have been developed by
Ben-Gurion University and ESHEL, and the advanced
leaning program at Tel Aviv University have merit, they
do not suffice for comprehensive advanced training and
credentialing. The formal development of an educational
pathway for specialist nurses in palliative care is a major
and important development.
Advanced training for physicians remains a problem,
particularly with the lack of cooperation from the scien-
tific committee of the Israel Medical Association to
recognize palliative medicine as a medical specialty. The
existing palliative care professional organizations, Tmi-
cha and the IPMS, should consider the approach of the
American Society for Hospice and Palliative Medicine,
which initiated its own internal accrediting system
before achieving formal specialist recognition. By devel-
oping its own training requirements and credentialing
framework, it would essentially provide responsible
quality control as well as providing a ready framework
for implementation if and when specialty or subspecialty
recognition is achieved. Once center, Shaare Zedek
Medical center, is providing a 2-year supervised fellow-
ship position.
It is especially important to both require palliative care
training for at least part of the staff in nursing homes,
and to expand palliative care services through primary
physicians with an emphasis on symptom management.
Achieving these educational goals requires both finan-
cial resources and trained manpower. In order to train
and educate a sufficient cadre of doctors, nurses and
other medical staff, it is unlikely that the system can
continue to rely on donations and temporary funds, as
has been done until now. As part of the efforts to
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develop the discipline, it will be necessary to divert
resources toward the education and training of profes-
sional manpower, in order to create specialists in pallia-
tive care who can in turn teach and train a large cadre
of people, and in order to deepen and expand the curri-
culum in the few on-the-job training programs currently
running.
As described above, in order to build on current pol-
icy, in July 2009, the Israeli Ministry of Health published
a policy directive requiring universal access to palliative
care within a few years. There is concern that success of
this initiative may be limited by the failure to specifically
relate to standards of care, standards of assessment, and
quality of care of this new endeavor [44].
Under-resourcing of palliative care is a substantial
problem. Ministry of Health policy initiatives for the
development and provision of new palliative care ser-
vices and training, without allocation of any new
resources for this purpose, may not produce substantial
change. This concern is especially grave given the
extreme limitation of resources already allotted to the
healthcare sector, which is struggling to address other
core elements of its mandate.
The Ministry would do well to reconsider and re-
assess this decision, for a number of reasons:
1. The basket of services mandated by the National
Health Insurance Law is based on the basket of services
supplied by the Clalit health plan in 1994, which at that
time did not provide any palliative services.
2. Since the law was passed nearly two decades ago,
there has been great development and an increase in
palliative care and hospice services in all Western coun-
tries. This increase is reflected in the number and types
of patients, illnesses and diagnoses, as well as the types
of services offered. In the US, for example, this is the
service that has enjoyed the greatest increase in funding
and resource allocation in the past decade. Conse-
quently, it is unrealistic to expect that these services be
developed and supplied in Israel in the required amount
and quality, without providing monetary remuneration
to the suppliers. Hospitals and health plans, and particu-
larly nursing facilities, are already functioning with mini-
mal budgets. It is unreasonable to expect that they
develop high-quality palliative services without receiving
separate funding for expended and new services. There
is very real concern that, in order to comply with the
Ministry of Health’s demands, they will develop pallia-
tive services of poor quality, unsatisfactory professional
standard and insufficient scope.
3. Studies in Israel and abroad, have shown that pallia-
tive services are more cost-effective than other medical
services for similar patients, without detracting from the
quality of care and the quality of their end of life. It is
therefore possible that investing resources in the
development and implementation of palliative services
could save much greater expenditures in the future.
A relevant issue, currently hotly debated in Israel, has
to do with equity in the availability and accessibility of
health services [56,57]. Research has recently revealed
large gaps in the scope and quality of Israeli medical
services between the major population centers and the
less densely populated outlying regions in the north and
south of the country, as well as gaps between population
groups with different socio-economic characteristics.
Thus, it is important to ensure that palliative services be
established and supplied throughout the country, and in
particular in the periphery and in places already suffer-
ing a lack of services.
Another issue that should be addressed is the aware-
ness and attitude of the Israeli public (both Jewish and
Arab) concerning the role of palliative care to improve
quality of life and to ensure the provision of comfort in
death and support for the family. Addressing these
issues should be predicated on credible data regarding
currently existing attitudes and barriers to the utilization
of palliative care services.
Conclusions
Palliative care services in Israel are substantially less well
developed than in the United States. The development
of grass-root programs, the existing infrastructure of
primary home care, processional organization and focal
areas of great expertise, provide excellent substrata for
the development of palliative care in Israel. Although
policy reforms are important and laudable, they are not
enough. Inadequate resource allocation, lack of educa-
tional guidelines at all levels of medical and paramedical
training, failure to facilitate the development of creden-
tialed manpower, and failure to develop specialty level
leadership, are among the key factors that continue to
thwart the development of palliative care in Israel.
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